Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Amanda Parsons, M.D., Appointed Deputy Chief Medical Officer of MetroPlus Health Plan

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/09/2019 | 02:01pm EST

MetroPlus Health Plan today announced the appointment of Amanda Parsons, M.D., as the health plan’s new Deputy Chief Medical Officer (DCMO). Dr. Parson’s assumed her new position on September 3.

“I am pleased to announce Dr. Parson’s appointment as Deputy Chief Medical Officer,” said Talya Schwartz, M.D., MetroPlus President and Chief Executive Officer. “We believe that she is supremely qualified to support Dr. Sanjiv S. Shah, who was appointed Chief Medical Officer last month, in providing the leadership we need to continue ensuring our members receive the excellent health services they deserve, and that they continue to rank us among the top plans in quality and patient satisfaction.”

“It is a privilege to assume this role and, in close collaboration with doctors Schwartz and Shah, as well as NYC Health + Hospitals, help provide access to medical care to our members as well as provide the wrap around services they need to stay their healthiest,” said Dr. Amanda Parsons. “I am passionate about improving health and health care quality, correctional health and reducing disparities for vulnerable populations, and committed to supporting the plan’s mission of inclusive, person-centered, quality-driven care.”

Amanda Parsons amassed extensive experience in physician leadership, population health management and health strategies, as well as management consulting, before joining MetroPlus as DCMO, where she now oversees disease and care management. She was formerly Vice President of Community & Population Health at Montefiore Health System where she directed community interventions aimed at improving health and wellness of patients, staff, and communities. She led Montefiore’s Bronx DSRIP activities and managed the design and implementation of programs including chronic disease pathways, transitions of care planning and social determinants of health screening/intervention. Prior to that, she was Deputy Commissioner of the Division of Health Care Access and Improvement at the NYC Department of Health & Mental Hygiene (DOHMH) where she was responsible for the Primary Care Information Project, Correctional Health Services, Primary Care Access and Planning, as well as IT, Finance, Admin and Legal bureaus.

Dr. Parsons previously worked for McKinsey & Company as an Engagement Manager serving health care clients. She earned her M.D. and M.B.A from Columbia University.

Dr. Parsons has served on numerous boards and is now the Board Chair of VIP Community Services in the Bronx. She is a recipient of Crain’s 2015 “40 Under 40” award and 2019 “Notable Women in Health Care” award.

About MetroPlus

MetroPlus Health Plan offers eligible New Yorkers a wide selection of health insurance options, including Medicaid, Medicare, Child Health Plus, MetroPlus Gold for city employees and SHOP for small businesses. The health plan offers access to primary, specialty, pharmacy and other health care services at low or no cost throughout New York City for people of all ages and varied health needs. MetroPlus members enjoy special perks including up to $1,000 in gym reimbursement, a rewards points program to redeem for gifts, and services to address social determinants of health like housing and food insecurity.

Since 1985, MetroPlus Health Plan has built a reputation for providing access to affordable, quality health care to residents of Brooklyn, the Bronx, Manhattan, Queens and Staten Island. A wholly-owned subsidiary of NYC Health + Hospitals, the nation’s largest public health system, MetroPlus is the plan of choice for over half a million New Yorkers and has a five-star rating based on the State’s 2018 Consumer’s Guide to Medicaid and Child Health Plus Managed Care Plans in New York City. The health plan’s robust network of primary care doctors and specialists includes many independent community providers. Culturally sensitive, and fluent in more than 40 languages, MetroPlus staff is as diverse as the great city it serves. For more information about MetroPlus plans, benefits, and services, visit www.metroplus.org and join the conversation at facebook.com/metroplushealth and twitter @metroplushealth.


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
10:02aPOLARIS : Fans Vote Aledo High School “Polaris' Most Driven Team” in Texas High School Football
BU
10:02aIDERA : ER/Studio Adds Extensive Support for Amazon Redshift
BU
10:02aWOLTERS KLUWER : Integrated Expert Solutions From Wolters Kluwer Help Clausen & Associates CPAs, PC Optimize Their Tax Compliance Practice and Build Tighter Client Advisory Relationships
BU
10:02aCEMAT A/S : No. 12/2019 - Upgrade of the expectation for 2019
AQ
10:02aEBAY : Partners with HyperX and Gamers Outreach for Charity Stream to Benefit Children in Hospitals
PR
10:02aGlobal Cultivators Market 2020-2024 | Evolving Opportunities with AGCO Corp. and BCS America | Technavio
BU
10:01aCHINA EVERGRANDE : Further announcement in relation to the proposed payment of dividend for the financial year of 2018
PU
10:01aYICHANG HEC CHANGJIANG PHARMACEUTICAL : Connected transaction entering into capital contribution agreement
PU
10:01aPURECIRCLE : Board and Management Changes
PU
10:01aYICHANG HEC CHANGJIANG PHARMACEUTICAL : Announcement on (1) the postponement of the 2019 4th egm; (2) cancellation of resolution on 2019 4th egm; (3) revised notice of 2019 4th egm and revised proxy form; (4) extension of period for closure of register of members; and (5) further delay in despatch of circular in relation to the discloseable transaction and connected transaction in relation to the proposed acquisition of the target assets from sunshine lake pharma
PU
Latest news "Companies"